P3 Health Partners Inc. Reaffirmed Earnings Guidance for the full-year ending December 31, 2024. For the year, the company Reaffirming revenue from $1.45 billion to $1.55 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.603 USD | +0.50% | -0.74% | -57.45% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.45% | 71.77M | |
+64.96% | 62.86B | |
-1.21% | 41.38B | |
+45.89% | 40.38B | |
-8.93% | 27.64B | |
+13.99% | 26.46B | |
-22.55% | 18.9B | |
+3.99% | 12.67B | |
+22.97% | 12.27B | |
+28.81% | 12.07B |
- Stock Market
- Equities
- PIII Stock
- News P3 Health Partners Inc.
- P3 Health Partners Inc. Reaffirms Earnings Guidance for the full-year ending December 31, 2024